In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


HemCon Medical Technologies Europe Ltd.

Division of HemCon Medical Technologies Inc.

Latest From HemCon Medical Technologies Europe Ltd.

Deals Shaping the Medical Industry (06/08)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Windhover's Strategic Transactions Database, providing comprehensive transaction coverage from 1991 to the present.
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
    • Biomaterials
  • Pharmaceuticals
    • Nutraceuticals
  • Therapeutic Areas
  • Cardiovascular
  • Dental & Oral Products
  • Wound Healing & Tissue Repair
  • Alias(es)
  • Alltracel Pharmaceuticals PLC
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Ireland
  • Parent & Subsidiaries
  • HemCon Medical Technologies Inc.
  • Senior Management
  • Anthony Richardson, CEO
    Nick Hart, CFO
  • Contact Info
  • HemCon Medical Technologies Europe Ltd.
    Phone: (353) 1 2352162
    10 Church Place